Beyond Air XAIR
NASDAQ XAIR
$5.15 -0.06 (-1.15%)
As of: Aug 20, 2026 · 3:59 PM EDT

Beyond Air (XAIR) Convertible Debt (2015 - 2016)

Beyond Air (XAIR) posted Convertible Debt of $2.9 million for Q4 2016, up 86.53% sequentially from $1.6 million in Q4 2015, and up 86.53% YoY from $1.6 million in Q1 2016.

Beyond Air (XAIR) Convertible Debt (2015 - 2016) Analysis & Trends

Beyond Air has reported Convertible Debt for 2 years, with the latest figure at $2.9 million in Q4 2016.

  • Quarterly Convertible Debt rose 86.53% year-over-year to $2.9 million in Q4 2016, while the trailing twelve-month figure through Dec 2016 was $2.9 million (up 86.53% YoY) and the FY2016 annual result came in at $2.9 million, up 86.53% from the prior year.
  • Convertible Debt grew to $2.9 million in Q4 2016 per XAIR's latest filing, from $1.6 million in the prior quarter.
  • Over five years, Convertible Debt peaked at $2.9 million in Q4 2016 and troughed at $1.6 million in Q4 2015.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn
10 Beyond Air 3.72 Mn -7.19 Mn 225,000.00

Historic Data

Download Data
DateValue
Dec 31, 2016 2.90 Mn
Dec 31, 2015 1.55 Mn